Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganciclovir gel for adenovirus conjunctivitis
NCT01600365Phase 3Unknown
- Sponsor
- Adapt
- Start
- May 2012
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of ganciclovir, sponsored by Adapt. Status: unknown.
02
Drugs
ganciclovir
Beyond the preview
Go deeper on NCT01600365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600365.